LumiraDx (NASDAQ:LMDX) stock is falling on Tuesday as the point-of-care diagnostics company’s shares retreat from a rally on Monday.
Investors will note that LMDX stock underwent a 217% rally on Monday. That came about after the company announced a partnership with AstraZeneca (NASDAQ:AZN).
That partnership has LumiraDx working with AstraZeneca on a heart and lung screening hub in England. The facility is expected to open its doors sometime next month.
News of that partnership inspired heavy trading of LMDX stock, with some 277 million shares changing hands during normal trading hours on Monday. For the record, that’s a massive surge in trading volume compared to the company’s daily average of 272,000 shares.
LMDX Stock Movement on Tuesday
Considering the incredible rally shares of LMDX stock underwent on Monday, it makes sense that the stock would give up some of those gains today. However, it doesn’t look like investors have to worry about it losing all of the ground it gained yesterday.
As of this writing, shares of LMDX stock are down 34.5% on Tuesday morning. That comes with some 7 million shares changing hands. While that’s still above its daily average trading volume, it doesn’t seem likely it will match yesterday’s movement.
Investors who are seeking out even more of the most recent stock market stories for today are in the right place!
InvestorPlace offers up all of the hottest stock market news that traders need to know about on Tuesday! A few examples of that include why shares of Aerwins Technologies (NASDAQ:AWIN) and Ascent Solar Technologies (NASDAQ:ASTI) stock are up today, as well as a dive into the biggest pre-market stock movers this morning. All of that news is ready to go at the links below!
More Tuesday Stock Market News
- Why Is Aerwins Technologies (AWIN) Stock Up 26% Today?
- Why Is Ascent Solar Technologies (ASTI) Stock Up 51% Today?
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
